| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
N/A |
| Shares
Out: |
19,300,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$57.98 - $57.98 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Larose Jeffrey |
Chief Scientific Officer |
• – – |
2014-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,600 |
6,525 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2014-02-03 |
4 |
AS |
$98.38 |
$214,578 |
D/D |
(2,179) |
4,925 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2014-02-03 |
4 |
OE |
$15.31 |
$33,360 |
D/D |
2,179 |
7,104 |
|
- |
|
| Harrison Seth Loring |
Director |
– • – |
2014-01-28 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,250 |
3,500 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2014-01-07 |
4 |
AS |
$100.00 |
$1,534,200 |
D/D |
(15,342) |
4,925 |
|
- |
|
| Harrison Seth Loring |
Director |
– • – |
2014-01-06 |
4 |
AS |
$99.29 |
$785,285 |
D/D |
(7,909) |
132,393 |
|
- |
|
| Knopf Lawrence J |
General Counsel |
• – – |
2014-01-06 |
4 |
AS |
$97.50 |
$83,948 |
D/D |
(861) |
3,527 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2014-01-02 |
4 |
AS |
$92.65 |
$202,261 |
D/D |
(2,179) |
20,267 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2014-01-02 |
4 |
OE |
$15.62 |
$34,036 |
D/D |
2,179 |
22,446 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2013-12-23 |
4 |
AS |
$91.12 |
$170,762 |
D/D |
(1,873) |
20,267 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2013-12-23 |
4 |
AS |
$91.06 |
$109,637 |
D/D |
(1,204) |
6,979 |
|
- |
|
| Yocher Robert E |
SVP, Regulatory & Quality |
• – – |
2013-12-23 |
4 |
AS |
$90.96 |
$43,843 |
D/D |
(482) |
3,870 |
|
- |
|
| Hathaway David R |
Chief Medical Officer |
• – – |
2013-12-23 |
4 |
AS |
$91.03 |
$54,800 |
D/D |
(602) |
1,302 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2013-12-23 |
4 |
AS |
$91.08 |
$394,883 |
D/D |
(4,333) |
53,554 |
|
- |
|
| Knopf Lawrence J |
General Counsel |
• – – |
2013-12-23 |
4 |
AS |
$90.99 |
$65,786 |
D/D |
(723) |
4,388 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2013-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,375 |
22,140 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2013-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
8,183 |
|
- |
|
| Yocher Robert E |
SVP, Regulatory & Quality |
• – – |
2013-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,000 |
4,352 |
|
- |
|
| Hathaway David R |
Chief Medical Officer |
• – – |
2013-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,904 |
|
- |
|
| Godshall Douglas Evan |
President & Chief Exec Officer |
• • – |
2013-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
57,887 |
|
- |
|
| Knopf Lawrence J |
General Counsel |
• – – |
2013-12-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
5,111 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2013-12-20 |
4 |
AS |
$91.63 |
$110,002 |
D/D |
(1,199) |
17,765 |
|
- |
|
| Larose Jeffrey |
Chief Scientific Officer |
• – – |
2013-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,800 |
18,964 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2013-12-20 |
4 |
AS |
$91.59 |
$128,848 |
D/D |
(1,405) |
5,683 |
|
- |
|
| Schuermann James |
SVP, Sales & Marketing |
• – – |
2013-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,917 |
7,088 |
|
- |
|
776 Records found
|
|
Page 10 of 32 |
|
|
